Drug-coated Balloons Market Revolutionizing Vascular Care A Growth Forecast for the Drug-Coated Balloons Market

Drug-coated Balloons Market to Record an Exponential CAGR by 2028 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Drug-coated Balloons Market- by Product (Drug-Coated Balloons for Peripheral Artery Disease, Drug-Coated Balloons for Coronary Artery Disease and Drug-Coated Balloons for Other Indications), End User (Hospitals, Cardiac Catherization Labs and Ambulatory Surgical Centers), Trends, Industry Competition Analysis, Revenue and Forecast To 2024-2031."

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1099

According to the latest research by InsightAce Analytic, the global Drug-coated Balloons market will be valued at US$ 600.3 Million in 2019. It is expected show a CAGR of 16.7% during a forecast period of 2021-2031.

Drug-Coated Balloons: A Minimally Invasive Solution for Vascular Disease
Drug-coated balloons (DCBs) are a novel approach to treating restenosis, a condition where arteries narrow again after angioplasty procedures. These balloons, often coated with paclitaxel,

offer a unique advantage over drug-coated stents. Early studies and clinical trials show promise for DCBs in addressing coronary and peripheral artery disease.

Factors Driving Market Growth
The global market for drug-coated balloons is expected to experience significant growth driven by several key factors:

• Growing Interest in Minimally Invasive Surgery: Patients and physicians increasingly prefer minimally invasive procedures like angioplasty with DCBs over traditional open surgery.

• Rising Prevalence of Vascular Disease: The global incidence of peripheral and coronary artery diseases is on the rise, creating a larger patient pool for DCB treatments.

• Large Patient Base in Developing Nations: Developing countries with growing populations are seeing an increase in cardiovascular disorders, presenting a significant market opportunity.

• Aging Population: The rapidly growing elderly population is more susceptible to cardiovascular issues, further fueling market demand.

• Increased R&D Investments: Growing investments in research and development for peripheral and coronary artery treatments are expected to lead to advancements in DCB technology.

Challenges and Considerations
Despite these promising trends, the market for drug-coated balloons faces some

challenges:
• High Costs: The high cost of materials and procedures associated with DCBs may limit wider adoption in some regions.

• Strict Regulations: Stringent regulatory requirements for DCB approval can slow market growth.

Regional Market Outlook
North America is expected to dominate the global DCB market due to a large patient population with cardiovascular disease and high healthcare access. Factors like new product approvals, growing clinical evidence, and expanding indications for existing DCBs are expected to contribute to continued market growth in this region.

The Asia Pacific market is anticipated to experience significant growth fueled by an aging population, increasing demand for advanced healthcare solutions, and a rising prevalence of cardiovascular diseases, particularly in China.

I hope this revised version improves readability by separating the explanation of DCBs from the market analysis and highlighting the specific factors driving growth and challenges.

Major market players operating in the Drug-coated Balloons market include
Medtronic, BD, Koninklijke Philips, B. Braun Melsungen, BIOTRONIK, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, Cardionovum, Concept Medical, ENDOCOR, Hexacath, iVascular SLU, M.A. Med Alliance, Minvasys, Orchestra BioMed, QT Vascular, RD Global-Invamed, Surmodics, Terumo, Welling, and Other prominent players.

Recent collaborations and agreements in the market:
• In May 2022, FDA approval for the investigational device exemption was given to MedAlliance's SELUTION SLR Drug-eluting Balloon. The novel sirolimus-eluting balloon known as the SELUTION SLR (Sustained Limus Release) gives a regulated and sustained drug release, much like a drug-eluting stent.

• In June 2020, iVascular SLU introduced Essential Pro, a ground-breaking coronary artery drug-coated balloon, on a global scale (DCB). The Essential Pro DCB improves on its predecessor in several ways, including more excellent safety and quick deflation times owing to an extension of the inflating channel and the availability of two different shaft options.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1099

Market Segments
Global Drug-coated Balloons Market, by Product, 2022-2028 (Value US$ Mn)
• Drug-Coated Balloons for Peripheral Artery Disease
• Drug-Coated Balloons for Coronary Artery Disease
• Drug-Coated Balloons for Other Indications

Global Drug-coated Balloons Market, by End User, 2022-2028 (Value US$ Mn)
• Hospitals
• Cardiac Catheterization Labs
• Ambulatory Surgical Centers

Global Drug-coated Balloons Market, by Region, 2022-2028 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• U.S.
• Canada

Europe Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Drug-coated Balloons Market, by Country, 2022-2028 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Drug-coated Balloons market
 To receive an industry overview and future trends of the Drug-coated Balloons market
 To analyze the Drug-coated Balloons market drivers and challenges
 To get information on the Drug-coated Balloons market value (US$ Mn) forecast to 2028
 Significant investments, mergers & acquisitions in the Drug-coated Balloons market industry

For More Information @ https://www.insightaceanalytic.com/customisation/1099

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.